Biotechnology – the use of living organisms and their components to generate knowledge and products – has become a cornerstone of innovation across health, agriculture and manufacturing. Beyond biomedical applications, biosolutions are emerging as a major opportunity to address global challenges, from climate change to food security. This policy brief explores the investment and regulatory policy landscapes in the European Union and the United States, highlighting shared challenges and lessons that can help accelerate sustainable innovation and strengthen participation in the global bioeconomy.
Boosting biotechnology innovation through agile regulation and finance instruments
Policy brief
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
Policy brief27 April 202612 Pages
-
Policy brief
Lessons learnt and implications for other countries
11 March 202610 Pages -
23 February 20269 Pages
-
17 February 202616 Pages
Related publications
-
14 April 202674 Pages
-
Working paper
Global linkages and the cross‑country distribution of the gains from AI
18 March 202679 Pages -
22 January 202688 Pages
-
23 December 202564 Pages
-
4 December 202563 Pages
-
Policy brief2 December 20258 Pages
-
20 October 202555 Pages